Latest Syneron Medical Ltd (ELOS) Headlines Min
Post# of 40
Posted On: 03/12/2014 8:37:37 PM
Latest Syneron Medical Ltd (ELOS) Headlines
Mindray Medical International Slips to Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 11, 1:50PM CDT
Mindray has seen a negative trend in earnings estimate revisions in the past 7 days.
Varian Medical Systems Hit 52-Week High - Analyst Blog
Souvik Guha - Zacks Investment Research - Tue Mar 11, 12:38PM CDT
Shares of VAR started escalating following its announcement of several events supporting the increased adoption of the company's technology and the exhibition of a comprehensive line of products in the pipeline.
Global Ablation Technologies Market 2012-2016: Major Cancer Diseases that Use Ablation Technology Devices are Discussed in Detail
M2 - Mon Mar 10, 11:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/5z78kx/global_ablation) has announced the addition of the "Global Ablation Technologies Market 2012-2016" report to their offering. The analysts forecast the Global Ablation Technologies market to grow at a CAGR of 10.52 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased demand for minimally invasive surgical procedures. The Global Ablation Technologies market has also been witnessing the trend of miniaturizing medical devices. However, the varying regulations for medical devices could pose a challenge to the growth of this market. Ablation technology devices are used for various clinical applications and Cancer therapy, and accounted for the largest segment of the Global Ablation Technologies market. The key vendors dominating this market space include Boston Scientific Corp., Medtronic Inc., St.Jude Medical Inc., and Varian Medical Systems Inc. The other vendors mentioned in the report are Accuray Inc., Alcon Laboratories Inc., AngioDynamics Inc., Arthrocare Corp., Atricure Inc., ATS Medical Inc., Biosense Webster Inc., BSD Medical Corporation, C.R. Bard Inc., Candela Corp., CardioGenesis Corp., CermaVEIN SAS, ConMed Corporation, Covidien plc, EDAP TMS S.A., Elekta AB, Endo Health Solutions Inc., Galil Medical Ltd., HealthTronics Inc., Hologic Inc., Idoman Ltd., Maquet Holding GmbH and Co. KG (Gentinge AB group), Microsulis Medical Ltd, Misonix Inc., nContact Surgical Inc., Olympus Corp., Relievant Medsystems, Rhythmia Medical Inc., Smith and Nephew plc, Solta Medical Inc., Syneron Medical Ltd., TheraGenics Corp., Urologix Inc., VNUS Medical Technologies Inc., and Zeltiq Aesthetics Inc. Commenting on the report, an analyst from the Healthcare team said: One of the upcoming trends in the Global Ablation Technology market is the rapid advancements in technology using ablation technology devices. Although the market for ablation technology devices is at a mature stage, the level of technology is still at a nascent stage; more devices with cutting-edge technology are expected to be introduced in the near future. Recently, laser ablation devices have been introduced to perform precise ablation of body tissue; these devices run on a laser energy transmission mechanism using fiber optics. This kind of device is used in transmyocardial revascularization and angioplasty. Another major advancement is the usage of catheter ablation for atrial fibrillation, which is commonly used to control tachy-arrhythmia. Thus, the rapid advancement in technology is an emerging trend that has a strong impact on the market. For more information visit http://www.researchandmarkets.com/research/5z...l_ablation About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Synergetics (SURG) in Focus: Stock Tumbles 11.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 10, 7:59AM CDT
Synergetics' shares fell by over 11% on the day. This continues the recent downtrend for SURG, as the stock is down nearly 6% since Feb 13.
Mindray Tops on Q4 Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 04, 2:23PM CST
International revenues grew 23.8% to $208.0 million while revenues from China grew at a slower pace of 8.3% to $160.4 million
Syneron Medical to Present at Barclays Global Healthcare Conference
PR Newswire - Mon Mar 03, 3:30PM CST
Syneron Medical Ltd. (NASDAQ:ELOS), the leading global aesthetic device company, announced today that Hugo Goldman, Chief Financial Officer, is scheduled to present at the Barclays Global Healthcare Conference in Miami, FL. This conference will allow institutional investors to meet with the Company and includes a formal presentation.
HeartWare Sees Narrower Loss but Misses Ests - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 03, 8:55AM CST
For full year 2013, HeartWare's loss was also narrower at $52.0 million or $3.24 per share compared with $86.6 million or $6.07 per share in 2012.
Special offer: Free online press release distribution with purchase of press release writing
PRNewsChannel.com - Fri Feb 21, 3:35PM CST
Jump start your content marketing with online press release articles to reach consumers directly
Syneron Reports Fourth Quarter and Full Year 2013 Results
PR Newswire - Thu Feb 20, 6:15AM CST
Syneron Medical Ltd. (NASDAQ: ELOS), the leading global aesthetic device company, today announced financial results for the three month and full year periods ended December 31, 2013.
Syneron Medical Acquires New Star Lasers
PR Newswire - Thu Feb 20, 6:05AM CST
Syneron Medical Ltd. (NASDAQ: ELOS), the leading global aesthetic device company, announced today that it has entered into an agreement to acquire New Star Lasers, Inc., which conducts business as CoolTouch, Inc. ("CoolTouch"), for approximately $11 million in cash and earn out based on certain milestones of up to $4 million until end of 2015. New Star Lasers develops, manufactures and markets the CoolTouch family of aesthetic devices. CoolTouch's 2013 unaudited revenues were approximately $8.9 million. Syneron anticipates the acquisition, which is expected to close in March 2014, will be accretive to the Company's GAAP earnings per share starting in 2015.
PHANTOGRAM New Album Voices Now Streaming At NPR Music
PR Newswire - Wed Feb 12, 5:00AM CST
NPR has premiered the new PHANTOGRAM record VOICES in its entirety as part of their exclusive FIRST LISTEN series. Due out February 18th via [REPUBLIC RECORDS], VOICES can now be heard via: http://www.npr.org/2014/02/04/271517810/first...ram-voices
Syneron Medical Shares Up 19.0% Since SmarTrend's Buy Recommendation (ELOS)
Comtex SmarTrend(R) - Wed Feb 05, 11:08AM CST
SmarTrend identified an Uptrend for Syneron Medical (NASDAQ:ELOS) on October 21st, 2013 at $9.40. In approximately 4 months, Syneron Medical has returned 19.04% as of today's recent price of $11.19.
Syneron Medical to Present at Leerink Swann 2014 Global Healthcare Conference
PR Newswire - Tue Feb 04, 3:15PM CST
Syneron Medical Ltd. (NASDAQ: ELOS), the leading global aesthetic device company, announced today that Hugo Goldman, Chief Financial Officer, is scheduled to participate in the Leerink Swann 2014 Global Healthcare Conference in New York City. Mr. Goldman will participate in a fireside chat presentation at the conference and will conduct meetings with institutional investors.
Concise Analysis on the International Skincare Devices Market - Forecasts to 2018
M2 - Thu Jan 30, 4:55AM CST
Research and Markets (http://www.researchandmarkets.com/research/xdr3vq/skincare_devices) has announced the addition of the "Concise Analysis on the International Skincare Devices Market - Forecasts to 2018" report to their offering. "Concise Analysis on the International Skincare Devices Market - Forecasts to 2018", studies the market for skincare devices from two aspects, the different product types and applications. Each of these segments has been further divided into sub-segments; the products segment has been categorized into diagnostic and treatment devices. Diagnostic devices include dermatoscopes, biopsy devices and image guidance systems whereas treatment devices comprise of lasabrasion devices, microdermabrasion devices, liposuction devices, electrosurgical devices, cryotherapy devices and LED therapy devices. Market size and forecasts for the period 2010 - 2018 have been provided for each of the segments and sub-segments, in terms of USD million, considering 2011 as the base year. The % CAGR for each market segment for the forecast period has been provided along with market size estimations. The market has been segmented geographically into four regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The respective market sizes and forecasts have been provided for each of these regions along with the CAGR. The market overview section features a detailed analysis of factors such as drivers, restraints and opportunities that affect the market dynamics, along with market attractiveness analysis and Porter's five force analysis for the skincare devices market. The competitive landscape section includes market share analysis of all the leading players in this market, in terms of percentage share in the year 2011. Some of the major players profiled in this report include Alma Lasers Ltd., Cynosure, Inc., Cutera, Inc., PhotoMedex, Inc., Solta Medical Ltd. and Syneron Medical. Key Topics Covered: 1 Preface 2 Executive Summary 3 Market Overview 4 Global Skincare Devices Market, by Product Type 5 Global Skincare Devices Market, by Application 6 Global Skincare Devices Market, by Geography 7 Competitive Landscape 8 Recommendations 9 Company Profiles Companies Mentioned: - Alma Lasers - Cutera - Cynosure - Lumenis - Michelson Diagnostics - Palomar Medical Technologies - Photomedex - Solta Medical - Syneron Medical For more information visit http://www.researchandmarkets.com/research/xd...re_devices
Shares of ELOS Up 29.3% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Jan 29, 9:48AM CST
SmarTrend identified an Uptrend for Syneron Medical (NASDAQ:ELOS) on October 21st, 2013 at $9.40. In approximately 3 months, Syneron Medical has returned 29.26% as of today's recent price of $12.15.
American Energy - NonOp, LLC (AENO) Raises Up To $500 Million Of Equity Commitments To Acquire Non-Operated Working Interests In Various Onshore U.S. Basins
PR Newswire - Wed Jan 29, 6:00AM CST
American Energy - NonOp, LLC (AENO), an affiliate of American Energy Partners, LP (AEP-LP), announced today that it has raised up to $500 million in equity commitments to pursue a business plan focused on the acquisition of non-operated working interests in various onshore basins in the U.S. Headquartered in Oklahoma City, AENO and AEP-LP are led by their founder, Chairman and CEO Aubrey K. McClendon.
Syneron Medical to Report Fourth Quarter and Full Year 2013 Financial Results on February 20, 2014
PR Newswire - Mon Jan 27, 8:00AM CST
Syneron Medical Ltd. (NASDAQ:ELOS), the leading global aesthetic device company, today announced that it will release fourth quarter and full year 2013 financial results before the market opens on Thursday, February 20, 2014. The financial results press release will be available on Syneron's website at investors.syneron.com.
Syneron Medical Has Returned 36.4% Since SmarTrend Recommendation (ELOS)
Comtex SmarTrend(R) - Wed Jan 22, 9:19AM CST
SmarTrend identified an Uptrend for Syneron Medical (NASDAQ:ELOS) on October 21st, 2013 at $9.40. In approximately 3 months, Syneron Medical has returned 36.38% as of today's recent price of $12.82.
Syneron Medical to Present at 16th Annual Needham Growth Conference
PR Newswire - Wed Jan 15, 1:57PM CST
Syneron Medical Ltd. (NASDAQ: ELOS), the leading global aesthetic device company, announced today that Hugo Goldman, Chief Financial Officer, is scheduled to participate in the 16th Annual Needham Growth Conference in New York City.
31.2% Return Seen to Date on SmarTrend Syneron Medical Call (ELOS)
Comtex SmarTrend(R) - Tue Jan 14, 5:12PM CST
SmarTrend identified an Uptrend for Syneron Medical (NASDAQ:ELOS) on October 21st, 2013 at $9.40. In approximately 3 months, Syneron Medical has returned 31.17% as of today's recent price of $12.33.
Mindray Medical International Slips to Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 11, 1:50PM CDT
Mindray has seen a negative trend in earnings estimate revisions in the past 7 days.
Varian Medical Systems Hit 52-Week High - Analyst Blog
Souvik Guha - Zacks Investment Research - Tue Mar 11, 12:38PM CDT
Shares of VAR started escalating following its announcement of several events supporting the increased adoption of the company's technology and the exhibition of a comprehensive line of products in the pipeline.
Global Ablation Technologies Market 2012-2016: Major Cancer Diseases that Use Ablation Technology Devices are Discussed in Detail
M2 - Mon Mar 10, 11:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/5z78kx/global_ablation) has announced the addition of the "Global Ablation Technologies Market 2012-2016" report to their offering. The analysts forecast the Global Ablation Technologies market to grow at a CAGR of 10.52 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased demand for minimally invasive surgical procedures. The Global Ablation Technologies market has also been witnessing the trend of miniaturizing medical devices. However, the varying regulations for medical devices could pose a challenge to the growth of this market. Ablation technology devices are used for various clinical applications and Cancer therapy, and accounted for the largest segment of the Global Ablation Technologies market. The key vendors dominating this market space include Boston Scientific Corp., Medtronic Inc., St.Jude Medical Inc., and Varian Medical Systems Inc. The other vendors mentioned in the report are Accuray Inc., Alcon Laboratories Inc., AngioDynamics Inc., Arthrocare Corp., Atricure Inc., ATS Medical Inc., Biosense Webster Inc., BSD Medical Corporation, C.R. Bard Inc., Candela Corp., CardioGenesis Corp., CermaVEIN SAS, ConMed Corporation, Covidien plc, EDAP TMS S.A., Elekta AB, Endo Health Solutions Inc., Galil Medical Ltd., HealthTronics Inc., Hologic Inc., Idoman Ltd., Maquet Holding GmbH and Co. KG (Gentinge AB group), Microsulis Medical Ltd, Misonix Inc., nContact Surgical Inc., Olympus Corp., Relievant Medsystems, Rhythmia Medical Inc., Smith and Nephew plc, Solta Medical Inc., Syneron Medical Ltd., TheraGenics Corp., Urologix Inc., VNUS Medical Technologies Inc., and Zeltiq Aesthetics Inc. Commenting on the report, an analyst from the Healthcare team said: One of the upcoming trends in the Global Ablation Technology market is the rapid advancements in technology using ablation technology devices. Although the market for ablation technology devices is at a mature stage, the level of technology is still at a nascent stage; more devices with cutting-edge technology are expected to be introduced in the near future. Recently, laser ablation devices have been introduced to perform precise ablation of body tissue; these devices run on a laser energy transmission mechanism using fiber optics. This kind of device is used in transmyocardial revascularization and angioplasty. Another major advancement is the usage of catheter ablation for atrial fibrillation, which is commonly used to control tachy-arrhythmia. Thus, the rapid advancement in technology is an emerging trend that has a strong impact on the market. For more information visit http://www.researchandmarkets.com/research/5z...l_ablation About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Synergetics (SURG) in Focus: Stock Tumbles 11.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 10, 7:59AM CDT
Synergetics' shares fell by over 11% on the day. This continues the recent downtrend for SURG, as the stock is down nearly 6% since Feb 13.
Mindray Tops on Q4 Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 04, 2:23PM CST
International revenues grew 23.8% to $208.0 million while revenues from China grew at a slower pace of 8.3% to $160.4 million
Syneron Medical to Present at Barclays Global Healthcare Conference
PR Newswire - Mon Mar 03, 3:30PM CST
Syneron Medical Ltd. (NASDAQ:ELOS), the leading global aesthetic device company, announced today that Hugo Goldman, Chief Financial Officer, is scheduled to present at the Barclays Global Healthcare Conference in Miami, FL. This conference will allow institutional investors to meet with the Company and includes a formal presentation.
HeartWare Sees Narrower Loss but Misses Ests - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 03, 8:55AM CST
For full year 2013, HeartWare's loss was also narrower at $52.0 million or $3.24 per share compared with $86.6 million or $6.07 per share in 2012.
Special offer: Free online press release distribution with purchase of press release writing
PRNewsChannel.com - Fri Feb 21, 3:35PM CST
Jump start your content marketing with online press release articles to reach consumers directly
Syneron Reports Fourth Quarter and Full Year 2013 Results
PR Newswire - Thu Feb 20, 6:15AM CST
Syneron Medical Ltd. (NASDAQ: ELOS), the leading global aesthetic device company, today announced financial results for the three month and full year periods ended December 31, 2013.
Syneron Medical Acquires New Star Lasers
PR Newswire - Thu Feb 20, 6:05AM CST
Syneron Medical Ltd. (NASDAQ: ELOS), the leading global aesthetic device company, announced today that it has entered into an agreement to acquire New Star Lasers, Inc., which conducts business as CoolTouch, Inc. ("CoolTouch"), for approximately $11 million in cash and earn out based on certain milestones of up to $4 million until end of 2015. New Star Lasers develops, manufactures and markets the CoolTouch family of aesthetic devices. CoolTouch's 2013 unaudited revenues were approximately $8.9 million. Syneron anticipates the acquisition, which is expected to close in March 2014, will be accretive to the Company's GAAP earnings per share starting in 2015.
PHANTOGRAM New Album Voices Now Streaming At NPR Music
PR Newswire - Wed Feb 12, 5:00AM CST
NPR has premiered the new PHANTOGRAM record VOICES in its entirety as part of their exclusive FIRST LISTEN series. Due out February 18th via [REPUBLIC RECORDS], VOICES can now be heard via: http://www.npr.org/2014/02/04/271517810/first...ram-voices
Syneron Medical Shares Up 19.0% Since SmarTrend's Buy Recommendation (ELOS)
Comtex SmarTrend(R) - Wed Feb 05, 11:08AM CST
SmarTrend identified an Uptrend for Syneron Medical (NASDAQ:ELOS) on October 21st, 2013 at $9.40. In approximately 4 months, Syneron Medical has returned 19.04% as of today's recent price of $11.19.
Syneron Medical to Present at Leerink Swann 2014 Global Healthcare Conference
PR Newswire - Tue Feb 04, 3:15PM CST
Syneron Medical Ltd. (NASDAQ: ELOS), the leading global aesthetic device company, announced today that Hugo Goldman, Chief Financial Officer, is scheduled to participate in the Leerink Swann 2014 Global Healthcare Conference in New York City. Mr. Goldman will participate in a fireside chat presentation at the conference and will conduct meetings with institutional investors.
Concise Analysis on the International Skincare Devices Market - Forecasts to 2018
M2 - Thu Jan 30, 4:55AM CST
Research and Markets (http://www.researchandmarkets.com/research/xdr3vq/skincare_devices) has announced the addition of the "Concise Analysis on the International Skincare Devices Market - Forecasts to 2018" report to their offering. "Concise Analysis on the International Skincare Devices Market - Forecasts to 2018", studies the market for skincare devices from two aspects, the different product types and applications. Each of these segments has been further divided into sub-segments; the products segment has been categorized into diagnostic and treatment devices. Diagnostic devices include dermatoscopes, biopsy devices and image guidance systems whereas treatment devices comprise of lasabrasion devices, microdermabrasion devices, liposuction devices, electrosurgical devices, cryotherapy devices and LED therapy devices. Market size and forecasts for the period 2010 - 2018 have been provided for each of the segments and sub-segments, in terms of USD million, considering 2011 as the base year. The % CAGR for each market segment for the forecast period has been provided along with market size estimations. The market has been segmented geographically into four regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The respective market sizes and forecasts have been provided for each of these regions along with the CAGR. The market overview section features a detailed analysis of factors such as drivers, restraints and opportunities that affect the market dynamics, along with market attractiveness analysis and Porter's five force analysis for the skincare devices market. The competitive landscape section includes market share analysis of all the leading players in this market, in terms of percentage share in the year 2011. Some of the major players profiled in this report include Alma Lasers Ltd., Cynosure, Inc., Cutera, Inc., PhotoMedex, Inc., Solta Medical Ltd. and Syneron Medical. Key Topics Covered: 1 Preface 2 Executive Summary 3 Market Overview 4 Global Skincare Devices Market, by Product Type 5 Global Skincare Devices Market, by Application 6 Global Skincare Devices Market, by Geography 7 Competitive Landscape 8 Recommendations 9 Company Profiles Companies Mentioned: - Alma Lasers - Cutera - Cynosure - Lumenis - Michelson Diagnostics - Palomar Medical Technologies - Photomedex - Solta Medical - Syneron Medical For more information visit http://www.researchandmarkets.com/research/xd...re_devices
Shares of ELOS Up 29.3% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Jan 29, 9:48AM CST
SmarTrend identified an Uptrend for Syneron Medical (NASDAQ:ELOS) on October 21st, 2013 at $9.40. In approximately 3 months, Syneron Medical has returned 29.26% as of today's recent price of $12.15.
American Energy - NonOp, LLC (AENO) Raises Up To $500 Million Of Equity Commitments To Acquire Non-Operated Working Interests In Various Onshore U.S. Basins
PR Newswire - Wed Jan 29, 6:00AM CST
American Energy - NonOp, LLC (AENO), an affiliate of American Energy Partners, LP (AEP-LP), announced today that it has raised up to $500 million in equity commitments to pursue a business plan focused on the acquisition of non-operated working interests in various onshore basins in the U.S. Headquartered in Oklahoma City, AENO and AEP-LP are led by their founder, Chairman and CEO Aubrey K. McClendon.
Syneron Medical to Report Fourth Quarter and Full Year 2013 Financial Results on February 20, 2014
PR Newswire - Mon Jan 27, 8:00AM CST
Syneron Medical Ltd. (NASDAQ:ELOS), the leading global aesthetic device company, today announced that it will release fourth quarter and full year 2013 financial results before the market opens on Thursday, February 20, 2014. The financial results press release will be available on Syneron's website at investors.syneron.com.
Syneron Medical Has Returned 36.4% Since SmarTrend Recommendation (ELOS)
Comtex SmarTrend(R) - Wed Jan 22, 9:19AM CST
SmarTrend identified an Uptrend for Syneron Medical (NASDAQ:ELOS) on October 21st, 2013 at $9.40. In approximately 3 months, Syneron Medical has returned 36.38% as of today's recent price of $12.82.
Syneron Medical to Present at 16th Annual Needham Growth Conference
PR Newswire - Wed Jan 15, 1:57PM CST
Syneron Medical Ltd. (NASDAQ: ELOS), the leading global aesthetic device company, announced today that Hugo Goldman, Chief Financial Officer, is scheduled to participate in the 16th Annual Needham Growth Conference in New York City.
31.2% Return Seen to Date on SmarTrend Syneron Medical Call (ELOS)
Comtex SmarTrend(R) - Tue Jan 14, 5:12PM CST
SmarTrend identified an Uptrend for Syneron Medical (NASDAQ:ELOS) on October 21st, 2013 at $9.40. In approximately 3 months, Syneron Medical has returned 31.17% as of today's recent price of $12.33.
(0)
(0)Syneron Medical Ltd (ELOS) Stock Research Links
Scroll down for more posts ▼